PreludeDx
@PreludeDx
Developers of DCISionRT, the first biological risk signature designed specifically for ductal carcinoma in situ (DCIS).
Your Biology, Your Decision®
ID:935917226443530240
http://www.preludedx.com 29-11-2017 17:03:50
586 Tweets
244 Followers
360 Following